HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy

HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy

Advanced studies have shown a biological correlation between hepatitis B virus (HBV) and B-cell lymphoma, especially diffuse large B-cell lymphoma (DLBCL). Patients with DLBCL infected with HBV (HBV-associated DLBCL) are clinically characterized by an advanced clinical stage, poor response to front-...

Full description

Bibliographic Details
Main Authors: Xin Wan, Ken H. Young, Ou Bai
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Immunology
Subjects:
hepatitis B virus
DLBCL
epigenetics
prognosis
chemo-resistance
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1216610/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1216610/full

Similar Items